7L8F

BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-2 from animal Rh.33172 (Wk38 time point)

これはPDB形式変換不可エントリーです。

7L8F の概要

• エントリーDOI: 10.2210/pdb7l8f/pdb
• EMDBエントリー: 23180 23231 23232
• 分子名称: Envelope glycoprotein gp160, Rh.33172 pAbC-2 Heavy Chain, Rh.33172 pAbC-2 Light Chain, ... (6 entities in total)
• 機能のキーワード: vaccine design, bg505, viral protein, polyclonal antibodies
• 由来する生物種: Human immunodeficiency virus 1; 詳細
• タンパク質・核酸の鎖数: 8
• 化学式量合計: 486227.61

構造登録者

Antanasijevic, A.,Sewall, L.M.,Ward, A.B. (登録日: 2020-12-31, 公開日: 2021-08-04, 最終更新日: 2024-10-23)

主引用文献

Antanasijevic, A.,Sewall, L.M.,Cottrell, C.A.,Carnathan, D.G.,Jimenez, L.E.,Ngo, J.T.,Silverman, J.B.,Groschel, B.,Georgeson, E.,Bhiman, J.,Bastidas, R.,LaBranche, C.,Allen, J.D.,Copps, J.,Perrett, H.R.,Rantalainen, K.,Cannac, F.,Yang, Y.R.,de la Pena, A.T.,Rocha, R.F.,Berndsen, Z.T.,Baker, D.,King, N.P.,Sanders, R.W.,Moore, J.P.,Crotty, S.,Crispin, M.,Montefiori, D.C.,Burton, D.R.,Schief, W.R.,Silvestri, G.,Ward, A.B.
Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM.
Nat Commun, 12:4817-4817, 2021

PubMed Abstract: Engineered ectodomain trimer immunogens based on BG505 envelope glycoprotein are widely utilized as components of HIV vaccine development platforms. In this study, we used rhesus macaques to evaluate the immunogenicity of several stabilized BG505 SOSIP constructs both as free trimers and presented on a nanoparticle. We applied a cryoEM-based method for high-resolution mapping of polyclonal antibody responses elicited in immunized animals (cryoEMPEM). Mutational analysis coupled with neutralization assays were used to probe the neutralization potential at each epitope. We demonstrate that cryoEMPEM data can be used for rapid, high-resolution analysis of polyclonal antibody responses without the need for monoclonal antibody isolation. This approach allowed to resolve structurally distinct classes of antibodies that bind overlapping sites. In addition to comprehensive mapping of commonly targeted neutralizing and non-neutralizing epitopes in BG505 SOSIP immunogens, our analysis revealed that epitopes comprising engineered stabilizing mutations and of partially occupied glycosylation sites can be immunogenic.

PubMed: 34376662
DOI: 10.1038/s41467-021-25087-4

実験手法

ELECTRON MICROSCOPY (3.66 Å)